CIK 0001595097 · Non-accelerated filer<br>Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464348039
- Phone
- 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,438
- in 2 filings, $16K under 10b5-1 plans
Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-19 | Altmeyer Anne Director | Grant or award | +3,800 | 9,991 | ||
| 2026-05-19 | Altmeyer Anne Director | Grant or award · Stock options (right to buy) | +12,300 | 12,300 | ||
| 2026-05-19 | Ben Yong Director | Grant or award | +3,800 | 11,383 | ||
| 2026-05-19 | Ben Yong Director | Grant or award · Stock options (right to buy) | +12,300 | 12,300 | ||
| 2026-05-19 | Pfeiffenberger Brent Director | Grant or award | +7,500 | 7,500 | ||
| 2026-05-19 | Pfeiffenberger Brent Director | Grant or award · Stock options (right to buy) | +24,700 | 24,700 | ||
| 2026-03-02 | Smethurst Dominic Chief Medical Officer | Sale | −6,097 | $8.30 | $51K | 89,790 |
| 2026-02-17 | Hodgson Ian Chief Operating Officer | Sale | −847 | $7.38 | $6K | 51,080 |
| 2026-02-13 | Moran Sean F. Chief Financial Officer | Sale 10b5-1 | −4,701 | $7.78 | $37K | 96,694 |
| 2026-02-13 | Cohen Yuval Chief Executive Officer | Sale 10b5-1 | −13,871 | $7.78 | $108K | 174,316 |
| 2026-02-03 | Smethurst Dominic Chief Medical Officer | Sale | −3,285 | $8.09 | $27K | 95,887 |
| 2026-02-03 | Hodgson Ian Chief Operating Officer | Sale | −2,415 | $8.09 | $20K | 51,927 |
| 2026-01-14 | Hodgson Ian Chief Operating Officer | Grant or award | +28,365 | 54,342 | ||
| 2026-01-14 | Hodgson Ian Chief Operating Officer | Grant or award · Stock options (right to buy) | +85,095 | 85,095 | ||
| 2026-01-14 | Smethurst Dominic Chief Medical Officer | Grant or award | +28,365 | 99,172 | ||
| 2026-01-14 | Smethurst Dominic Chief Medical Officer | Grant or award · Stock options (right to buy) | +85,095 | 85,095 | ||
| 2026-01-14 | Moran Sean F. Chief Financial Officer | Grant or award | +28,082 | 101,395 | ||
| 2026-01-14 | Moran Sean F. Chief Financial Officer | Grant or award · Stock options (right to buy) | +84,247 | 84,247 | ||
| 2026-01-14 | Cohen Yuval Chief Executive Officer | Grant or award | +50,000 | 188,187 | ||
| 2026-01-14 | Cohen Yuval Chief Executive Officer | Grant or award · Stock options (right to buy) | +150,000 | 150,000 |
Page 2 of 10 · 200 trades